Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-24 @ 7:12 PM
NCT ID:
NCT00747903
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Biopsy-proven basal cell carcinoma on the trunk or extremities
* Tumor size ≤ 2 cm in diameter
PATIENT CHARACTERISTICS:
* Willing and able to comply with all follow-up requirements
* Mentally competent
* No active, localized, or systemic infections
* Not immunocompromised
* No coagulation disorder
* No photosensitivity or allergy to sunlight
* Not pregnant or nursing
* No history of keloid formation
* No history of cutaneous photosensitization, porphyria, hypersensitivity to porphyrins, or photodermatosis
PRIOR CONCURRENT THERAPY:
* No prior gold therapy
* No prior radiotherapy to the trunk and extremities
* More than 24 months since prior oral retinoids (e.g., isotretinoin or acitretin) or photosensitizing drugs (e.g., Declomycin®)
* More than 1 year since prior collagen or other injections, Botox® injections, chemical peels, dermabrasion, or resurfacing procedures
* More than 1 month since prior topical retinoid therapy
* No concurrent aspirin or antioxidants
* No concurrent anticoagulation medications
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT00747903
Study Brief:
Protocol Section:
NCT00747903